Mervyn B. Forman

Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

B Olafsson, Mervyn B. Forman, David W. Puett et al. · Circulation · 1987 · 378 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Increased Adventitial Mast Cells in a Patient with Coronary Spasm

Mervyn B. Forman, John A. Oates, David Robertson et al. · New England Journal of Medicine · 1985 · 295 citations

Medicine, Cardiology, Pharmacology +15

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial

Robert A. Kloner, Mervyn B. Forman, Raymond J. Gibbons et al. · European Heart Journal · 2006 · 246 citations · Full text

Medicine, Cardiology, Pharmacology +12

Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

Christos J. Pitarys, Renu Virmani, Harry D. Vildibill et al. · Circulation · 1991 · 182 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.

David G. Babbitt, Renu Virmani, Mervyn B. Forman · Circulation · 1989 · 164 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +14